LSB INDUSTRIES INC (LXU)

US5021601043 - Common Stock

9.1  +1.66 (+22.31%)

Premarket: 9.1 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LXU. LXU was compared to 85 industry peers in the Chemicals industry. LXU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LXU is valued expensive and it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

LXU had positive earnings in the past year.
LXU had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LXU reported negative net income in multiple years.
Of the past 5 years LXU 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of LXU (-1.31%) is worse than 71.08% of its industry peers.
Looking at the Return On Equity, with a value of -3.12%, LXU is doing worse than 65.06% of the companies in the same industry.
LXU's Return On Invested Capital of 0.78% is on the low side compared to the rest of the industry. LXU is outperformed by 74.70% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LXU is above the industry average of 6.59%.
The last Return On Invested Capital (0.78%) for LXU is well below the 3 year average (10.55%), which needs to be investigated, but indicates that LXU had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.31%
ROE -3.12%
ROIC 0.78%
ROA(3y)-0.42%
ROA(5y)-3.91%
ROE(3y)0.75%
ROE(5y)-8.26%
ROIC(3y)10.55%
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 1.90%, LXU is doing worse than 74.70% of the companies in the same industry.
The Gross Margin of LXU (10.34%) is worse than 83.13% of its industry peers.
In the last couple of years the Gross Margin of LXU has grown nicely.
Industry RankSector Rank
OM 1.9%
PM (TTM) N/A
GM 10.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.26%
GM growth 5Y28.31%

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LXU is still creating some value.
LXU has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, LXU has more shares outstanding
Compared to 1 year ago, LXU has an improved debt to assets ratio.

2.2 Solvency

LXU has an Altman-Z score of 1.49. This is a bad value and indicates that LXU is not financially healthy and even has some risk of bankruptcy.
LXU has a Altman-Z score of 1.49. This is in the lower half of the industry: LXU underperforms 67.47% of its industry peers.
LXU has a debt to FCF ratio of 54.09. This is a negative value and a sign of low solvency as LXU would need 54.09 years to pay back of all of its debts.
The Debt to FCF ratio of LXU (54.09) is worse than 65.06% of its industry peers.
LXU has a Debt/Equity ratio of 0.96. This is a neutral value indicating LXU is somewhat dependend on debt financing.
The Debt to Equity ratio of LXU (0.96) is worse than 69.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 54.09
Altman-Z 1.49
ROIC/WACC0.09
WACC8.71%

2.3 Liquidity

A Current Ratio of 2.53 indicates that LXU has no problem at all paying its short term obligations.
LXU has a better Current ratio (2.53) than 63.86% of its industry peers.
LXU has a Quick Ratio of 2.36. This indicates that LXU is financially healthy and has no problem in meeting its short term obligations.
LXU has a better Quick ratio (2.36) than 84.34% of its industry peers.
Industry RankSector Rank
Current Ratio 2.53
Quick Ratio 2.36

3

3. Growth

3.1 Past

The earnings per share for LXU have decreased strongly by -71.54% in the last year.
Looking at the last year, LXU shows a very negative growth in Revenue. The Revenue has decreased by -25.14% in the last year.
The Revenue has been growing by 9.44% on average over the past years. This is quite good.
EPS 1Y (TTM)-71.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-25.14%
Revenue growth 3Y19.11%
Revenue growth 5Y9.44%
Sales Q2Q%-4.44%

3.2 Future

LXU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.08% yearly.
LXU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.94% yearly.
EPS Next Y-55.35%
EPS Next 2Y7.32%
EPS Next 3Y8.08%
EPS Next 5YN/A
Revenue Next Year-13.24%
Revenue Next 2Y-4.86%
Revenue Next 3Y-0.07%
Revenue Next 5Y4.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.00, LXU can be considered very expensive at the moment.
LXU's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of LXU to the average of the S&P500 Index (27.10), we can say LXU is valued inline with the index average.
With a Price/Forward Earnings ratio of 20.79, LXU is valued on the expensive side.
LXU's Price/Forward Earnings is on the same level as the industry average.
LXU is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.41, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26
Fwd PE 20.79

4.2 Price Multiples

LXU's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, LXU is valued a bit more expensive than the industry average as 65.06% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 72.16
EV/EBITDA 9.64

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.32%
EPS Next 3Y8.08%

0

5. Dividend

5.1 Amount

No dividends for LXU!.
Industry RankSector Rank
Dividend Yield N/A

LSB INDUSTRIES INC

NYSE:LXU (1/13/2025, 8:04:00 PM)

Premarket: 9.1 0 (0%)

9.1

+1.66 (+22.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)N/A N/A
Inst Owners52.77%
Inst Owner Change-2.04%
Ins Owners4.64%
Ins Owner Change-0.89%
Market Cap651.74M
Analysts73.33
Price Target10 (9.89%)
Short Float %3.67%
Short Ratio7.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)104.22%
Min EPS beat(2)100%
Max EPS beat(2)108.44%
EPS beat(4)3
Avg EPS beat(4)55.19%
Min EPS beat(4)-154%
Max EPS beat(4)166.32%
EPS beat(8)5
Avg EPS beat(8)16.86%
EPS beat(12)7
Avg EPS beat(12)37.09%
EPS beat(16)8
Avg EPS beat(16)18.81%
Revenue beat(2)1
Avg Revenue beat(2)3.09%
Min Revenue beat(2)-6.62%
Max Revenue beat(2)12.81%
Revenue beat(4)3
Avg Revenue beat(4)4.15%
Min Revenue beat(4)-6.62%
Max Revenue beat(4)12.81%
Revenue beat(8)6
Avg Revenue beat(8)2.22%
Revenue beat(12)9
Avg Revenue beat(12)2.92%
Revenue beat(16)10
Avg Revenue beat(16)2.29%
PT rev (1m)2.08%
PT rev (3m)9.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)54.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-61.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE 26
Fwd PE 20.79
P/S 1.25
P/FCF 72.16
P/OCF 6.54
P/B 1.31
P/tB 1.31
EV/EBITDA 9.64
EPS(TTM)0.35
EY3.85%
EPS(NY)0.44
Fwd EY4.81%
FCF(TTM)0.13
FCFY1.39%
OCF(TTM)1.39
OCFY15.28%
SpS7.26
BVpS6.97
TBVpS6.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.31%
ROE -3.12%
ROCE 0.93%
ROIC 0.78%
ROICexc 0.96%
ROICexgc 0.97%
OM 1.9%
PM (TTM) N/A
GM 10.34%
FCFM 1.74%
ROA(3y)-0.42%
ROA(5y)-3.91%
ROE(3y)0.75%
ROE(5y)-8.26%
ROIC(3y)10.55%
ROIC(5y)N/A
ROICexc(3y)14.03%
ROICexc(5y)N/A
ROICexgc(3y)14.07%
ROICexgc(5y)N/A
ROCE(3y)12.72%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.26%
GM growth 5Y28.31%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 54.09
Debt/EBITDA 5.88
Cap/Depr 127.04%
Cap/Sales 17.41%
Interest Coverage 250
Cash Conversion 122.69%
Profit Quality N/A
Current Ratio 2.53
Quick Ratio 2.36
Altman-Z 1.49
F-Score4
WACC8.71%
ROIC/WACC0.09
Cap/Depr(3y)71.9%
Cap/Depr(5y)62.11%
Cap/Sales(3y)7.59%
Cap/Sales(5y)8.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y-55.35%
EPS Next 2Y7.32%
EPS Next 3Y8.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-25.14%
Revenue growth 3Y19.11%
Revenue growth 5Y9.44%
Sales Q2Q%-4.44%
Revenue Next Year-13.24%
Revenue Next 2Y-4.86%
Revenue Next 3Y-0.07%
Revenue Next 5Y4.94%
EBIT growth 1Y-92.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.86%
EBIT Next 3Y38.89%
EBIT Next 5YN/A
FCF growth 1Y-96.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.6%
OCF growth 3YN/A
OCF growth 5Y50.82%